投融资数据库
免费查数据
注册送3天会员
首页>投融资
NanoPass Technologies
未透露
NanoPass is a medical device company focused on transdermal drug delivery.In August 2009, the Infectious Disease Research Institute (IDRI) entered into an agreement to use NanoPass Technologies' MicronJet microneedle intradermal delivery technology to be used with products against diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy, and also diagnostic skin tests.In February 2004, NanoPass signed an agreement with GlaxoSmithKline plc's Biopharmaceutical Centre of Excellence for Drug Discovery to develop NanoPass's MicroPyramid technology for the delivery of vaccines. In April 2005, The Britech Foundation gave the collaboration an STG 0.45 million (US $0.86 million) grant twhich would fund development of the technology for 2 years.In July 2012, the company closed a new round of financing which was led by Israel HealthCare Ventures
基本信息
-
公司全称NanoPass Technologies Ltd
-
类型皮内给药技术开发商
-
产业领域医疗器械、治疗设备
-
公司人数15人以下
-
地址3, Golda Me'ir NESS-ZIONA 7403648; IL; Telephone: +97289462905; Fax: +97235214901;
-
联系电话97289462905
-
邮箱info@nanopass.com
-
成立时间2000-01-01
相关投融资企业
未公开
Xeltis 通过跨国研发平台和可降解聚合物技术,致力于“让人体自行修复并留下永久性血管/瓣膜”。其在荷兰/瑞士的双总部和美国研发中心构成全球化研发网络。Xeltis BV 是集团在欧洲的关键执行机构,负责临床试验、监管沟通及未来的商业化落地,近期已取得冠状动脉旁路移植物的积极临床数据,标志着该技术向实际临床应用迈出重要一步。
A+轮
上海美微达医疗科技有限公司成立于2021年7月,是一家具有自主研发、生产、销售II类 & III类医疗器械的高新企业。是一家围绕肿瘤微创介入领域,面向全球市场,提供整体解决方案的医疗器械高科技公司。公司的宗旨:专注于微创介入治疗领域,为医生和患者提供满足临床需求的高质量产品。
天使轮
飞马医疗成立于2023年,专注开发泌尿,男科,胃肠领域的创新诊治产品,解决前列腺增生,ED,二型糖尿病,肥胖等疾病,拥有热蒸汽消融,磁性材料成型等技术平台。



浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息